The Natural History Of tPa
==========================

[@B77] noted that the blood of patients who died suddenly was not completely coagulated. [@B25] observed the spontaneous dissolution of blood clots. Fifty years later, [@B26] postulated the existence of an endogenous fibrinolytic enzyme. Accordingly, [@B40] revealed a proteolytic activity in serum globulin fraction, later identified as the fraction containing a precursor of plasmin. [@B18] proposed that this inactive circulating precursor, named plasminogen, could be activated by bacterial extracts like streptokinase. [@B67] completed the description of the plasminogen activation cascade. In parallel, [@B22] identified tPA, at this time named fibrikinase, in different organs), later characterized to mediate fibrinolysis ([@B31]; [@B1]; [@B2]). tPA was then purified from human vessels and uterus in [@B11], [@B97] and in larger amounts from Bowes melanoma cell line allowing its biochemical characterization ([@B21]; [@B20]). [@B89] succeeded in cloning and expressing recombinant tPA, providing the primary structure of tPA. tPA is a protein of 527 amino-acids including three glycosylation sites and 17 disulfide bridges ([@B89]). [@B19] then provided evidence that tPA could facilitate the dissolution of blood clots by inducing the degradation of fibrin in a plasminogen-dependent manner. tPA is now used in the clinic to promote fibrinolysis, especially at the acute phase of ischemic stroke either alone ([@B81]) or combined with thrombectomy ([@B15]; [@B34]).

In addition to this fibrinolytic function at the origin of its discovery, an increasing number of studies have since the mid-90s, discovered functions of tPA within the brain parenchyma. In particular, tPA is believed to control neuronal fate during several CNS disorders, including multiple sclerosis, Alzheimer's disease, and stroke. The aim of this review is to summarize and discuss structure-function studies related to the influence of tPA on neuronal death and survival.

tPA or tPAs?
============

The mature form of tPA is a mosaic protein of five distinct modules, which, from its N-terminal end to its C-terminal end, are: a finger domain (F), an epidermal growth factor-like domain (EGF), two kringle domains (K1 and K2), and a serine protease proteolytic domain (SP). The finger domain is involved in tPA binding to fibrin and is necessary to promote fibrinolytic activity at low plasminogen activator concentrations ([@B52]). In the brain, other functions attributed to the finger domain include its ability to cross the blood--brain barrier ([@B6]), its astrocytic clearance ([@B16]) and some of its signaling pathways ([@B103]; [@B91]). The EGF-like domain shows homology with EGF. Both the trophic and mitogenic functions of tPA have been attributed to this domain ([@B61]; [@B83]; [@B24]; [@B36]). The EGF-like domain has been also reported to contribute to the hepatic recapture of tPA ([@B37]). The kringle domains fold into large loops stabilized by three disulfide bridges. Because of the high-mannose-type glycosylation at Asn117, K1 is of major importance in the uptake of tPA by mannose receptors on liver endothelial cells *in vivo* and *in vitro* ([@B49]). The K2 domain and more specifically its lysine binding site (LBS) is involved in the capacity of tPA to bind and activate substrates and/or receptors such as plasminogen, PDGF-CC (platelet derived growth factor-CC; [@B32]) and NMDAR (*N*-methyl-[D]{.smallcaps}-aspartate receptor; [@B64]). The K1 of tPA does not possess a LBS ([@B47]). The C-terminal domain supports the catalytic activity of tPA and forms the catalytic triad (*His 322, Asp 371, and Ser 478)* involving an aspartic acid residue (Asp371) hydrogen-bonded to a histidine (His322), which itself is hydrogen-bonded to a serine (Ser478).

As detailed here after, the literature suggests that there is not one but several forms of tPAs.

Long and Short Variants
-----------------------

The pro-form of tPA is a molecule of 562 amino acids. The signal peptide and a pro-peptide of, respectively, 22 and 10 amino acids should be removed before storage in vesicles and release. Three additional amino acids (Gly--Ala--Arg) at the N-terminal end of the molecule can be also removed leading to the release of either the long variant (L-tPA) or the short variant (S-tPA) of 530 and 527 amino acids, respectively ([@B45]; [@B9]). These tPAs include 17 disulfide bridges.

sc-tPA vs. tc-tPA
-----------------

In contrast to the other members of the chymotrypsin family, tPA is not synthesized and secreted as a "true" zymogen ([@B69]). Like other members of the family, the secreted single-chain tPA (sc-tPA; **Figure [1A](#F1){ref-type="fig"}**) can be processed into a two-chain form tPA (tc-tPA; **Figure [1B](#F1){ref-type="fig"}**) by plasmin or kallikrein ([@B115]; [@B43]). However, sc-tPA is an unusually active zymogen (high intrinsic proteolytic activity, low zymogenicity) that does not require proteolytic processing to be active but relies on the presence of an allosteric regulator, such as fibrin ([@B109]). The passage from the sc-tPA to the tc-tPA form results from the hydrolysis of the peptide bond linking the Arg275 and the Ile276, both parts of the protein remaining connected by a disulfide bridge between Cys299 (heavy chain A) and Cys430 (light chain B) and a novel salt bridge between Arg302 and Glu445 ([@B51]). In the absence of an allosteric regulator such as fibrin, tc-tPA is fivefold catalytically more active than sc-tPA ([@B94]; [@B115]; [@B107]; [@B90]; [@B12]). However, in the presence of fibrin, both sc-tPA and tc-tPA display the same catalytic activity ([@B109]).

![**Schematic representations of the primary structure of sc-tPA (A) and tc-tPA (B).** Each amino acid is represented by its single letter symbol. Sites of N- (![](fncel-09-00415-i001.jpg)) or O-glycosylation (![](fncel-09-00415-i002.jpg)) are showed. The active site residues His322, Asp371, and Ser478 are marked by stars. The amino acids involved in the structure of the lysine binding site are noted with asterisks. The black bars indicate disulfide bonds. The black bar dotted indicate salt bond. The double-arrow indicates the cleavage site for conversion of sc-tPA to tc-tPA.](fncel-09-00415-g001){#F1}

Type I vs. Type II tPA
----------------------

Type plasminogen activator is a glycoprotein containing three major N-glycosylation sites. Two glycosylations are constitutives at Asn117 within the kringle 1 domain and at Asn448 within the serine protease domain. A third one is alternative at Asn184 within the kringle 2 domain. Type I tPA is glycosylated at Asn117, Asn184, and Asn448, while type II tPA is glycosylated only at Asn117 and Asn448 ([@B92]; [@B105]; [@B78]; [@B44]). Asn184 acts as a switch that enables long-distance communication between fibrin-binding residues (achieved by the finger domain) and the catalytic site in the protease domain ([@B95]). Glycosylation of Asn184 (i.e., type I) reduces the ability of tPA to activate plasminogen as well as its binding to fibrin ([@B28]; [@B120]; [@B8]). Type I sc-tPA seems to be more stable than type II sc-tPA regarding its conversion to tc-tPA ([@B119]; [@B8]; **Figure [2](#F2){ref-type="fig"}**). tPA also contains a O-linked fucose at Thr61 (occupancy 100%) within the EGF domain ([@B38]) and potentially an additional N-glycosylation site at Asn142 within the K1 domain (occupancy 1%; [@B13]).

![**The diversity of tPAs.** L-tPA and S-tPA are released under their single chain form (sc-tPA), possibly cleaved into their two-chain form (tc-tPA) by plasmin or kalikrein. Each form of tPA exists in two glycosylated states, types I or II.](fncel-09-00415-g002){#F2}

Is tPA Good or Bad for Neuronal Survival?
=========================================

The Facts
---------

The group of Sidney Strickland was the first to demonstrate that tPA deficient mice were more sensitive to hippocampal neuronal death induced by both NMDAR- and non-NMDAR-agonists ([@B112]), an effect dependent of the ability of tPA to activate plasminogen into plasmin ([@B110],[@B111]; **Figure [3A](#F3){ref-type="fig"}**). Accordingly, several studies have reported that inhibitors of tPA, such as neuroserpin and type 1 plasminogen activator inhibitor (PAI-1) protect neurons against toxicity induced by the over-activation of NMDARs ([@B14]; [@B126]; [@B33]; [@B54]). Exogenous tPA was then reported pro-neurotoxic, on cortical neurons, in paradigms of *in vitro* or *in vivo* excitotoxicity mediated by over-activation of NMDAR ([@B80]; [@B59]; [@B96]; [@B87]; **Figure [3B](#F3){ref-type="fig"}**). The tPA was also reported to promote damages on Purkinje cells ([@B65]; [@B57], [@B58]; [@B23]; **Figure [3C](#F3){ref-type="fig"}**), especially by altering the neurotrophic mechanisms that control their postnatal development ([@B57], [@B58]).

![**Possible mechanisms of tPA on neuronal survival. (A)** Hippocampal neurons; **(B)** cortical neurons; **(C)** cerebellar neurons. NSP, neuroserpin; Pln, plasmin; PAI-1, plasminogen activator inhibitor-1; NMDAR, *N*-methyl-[D]{.smallcaps}-aspartate receptor; EGFR, epidermal growth factor receptor; KA-R, kainate receptor; A-II, annexin II receptor.](fncel-09-00415-g003){#F3}

Both plasmin-dependent and plasmin-independent mechanisms have been proposed to explain the potentiation of NMDAR signaling by tPA ([@B80]; [@B88]; [@B74]), but several recent studies agree that it can occur independently of plasminogen activation ([@B101]; [@B27]; [@B86]). For instance, tPA can interact with the GluN1 subunit of NMDAR involving the LBS of its K2 domain ([@B80]; [@B29]; [@B50]; [@B64]; [@B86]). Our group reported that the cleavage of the amino-terminal domain of GluN1 subunit is necessary for enhancement of NMDAR signaling by tPA ([@B80]; [@B29]). In the brain of protease nexin-1 (PN-1, an inhibitor of tPA) deficient mice, [@B50], demonstrated an increase in the proteolytic activity of tPA, correlated with a decrease in the amount of the GluN1 subunit of the NMDA receptor. However, no cleavage of GluN1 was observed despite the interaction of tPA with the GluN1 subunits of NMDAR ([@B50]). Other groups did not detect tPA-dependent cleavage of GluN1, despite enhancement of NMDAR function by exogenous tPA in cortical cultures ([@B101]). In a more recent study, it was reported that sc-tPA, but not tc-tPA can promote NMDAR signaling and neurotoxicity in cortical neurons ([@B86]; [@B10]). These data were the first to describe a differential function of sc-tPA and tc-tPA. tPA would also act on neuronal death by engaging Low density lipoprotein related protein (LRP) receptors, which in turn would enhance Ca^2+^ downstream of NMDAR ([@B101]). More recent data obtained from Schwann cells showed that tPA can promote NMDAR signaling independently of LRP1 ([@B71]). Similarly, in PC12 and N2a neuron-like cells, tPA may signal through a complex containing NMDAR, LPR1, and Trk receptors ([@B70]). Plasmin, which is generated by the tPA-dependent conversion of plasminogen, has also been reported to cleave NMDARs, specifically the GluN2 subunit. This cleavage can occur at two sites: Lys317 on GluN2A, which relieves Zn^2+^ inhibition and thereby increases NMDAR function ([@B125]), and Arg67 on GluN2B, which increases sensitivity of the NMDAR to glycine ([@B79]). Whether tPA-dependent plasmin formation counteracts or interferes with tPA-dependent NMDAR activation is still under debate. Whatever the mechanism, all these studies showed that tPA can increase NMDAR signaling.

By contrast, other studies, in particular using transgenic mice over-expressing tPA in neurons (T4 transgenic mice) or tPA KO mice, suggested that tPA can also have neuroprotective effects ([@B36]; [@B123]). These two studies also proposed a mechanism dependent on the activation of NMDAR and independent on plasmin. *In vitro* and *ex vivo* studies also reported pro-survival effects of tPA on neurons ([@B61]; [@B55]; [@B93]; [@B10]; [@B56]), mainly anti-apoptotic effects. Also interesting, tPA was reported to attenuate zinc-induced neuronal cell death independently of its proteolytic action ([@B48]; [@B104]). Despite the heterogeneity of the paradigms used in these different studies, they all showed that this effect of tPA occurs independently of its proteolytic activity, with the activation of either PI3K/Akt, AMPK- or mTor-HIF-1alpha-dependent signaling pathways needed ([@B24]; [@B123]; **Figure [3B](#F3){ref-type="fig"}**). Two candidates have been proposed as the receptors mediating the pro-survival effects of tPA: Annexin II and EGF receptor ([@B103]; [@B123]; [@B10]; [@B56]). The ability of tPA to convert the pro-neurotrophins (BDNF, NGF) to their active forms ([@B84]) is also a possible explanation to the pro-survival effects of tPA.

What are the Possible Explanations of the Differential Effects of tPA on Neuronal Survival? (**Table [1](#T1){ref-type="table"}**)
==================================================================================================================================

###### 

Reported effects of tPA on challenged neurons.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference         Model(s)                                                                                                                                                                                                                                                                                     tPA                                                Mechanism(s)
  ----------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------- -------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Beneficial**                                                                                                                                                                                                                                                                                                                                                    

  [@B48]            *In vitro*: cortical cultures exposure to 300 mM zinc (mice)                                                                                                                                                                                                                                 Exogenous 10 μg/ml                                 Independently of its proteolytic action, tPA attenuated zinc-induced cell death

                    *In vivo*: kainate injection (10 mg/kg) in rats                                                                                                                                                                                                                                              Intracerebroventricular tPA 1 mg/ml                tPA attenuated kainate seizure-induced neuronal death in the hippocampus

                                                                                                                                                                                                                                                                                                                                                                    

  [@B30]            *In vitro*: OGD, 2.5 h\                                                                                                                                                                                                                                                                      Exogenous 1,000 IU                                 tPA protects neurons from oxygen glucose deprivation (OGD) by a non-proteolytic action
                    Cultured hippocampal neurons from rats (DIV 7--10)                                                                                                                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                                                                                                    

  [@B17]            *Ex vivo*: striatal neurons WT and tPA --/-- mice subjected to OGD                                                                                                                                                                                                                           Endogenous                                         tPA enhanced ischemia-induced neuronal damage by facilitating apoptosis rather than necrosis

                                                                                                                                                                                                                                                                                                                                                                    

  [@B124]           *In vitro*: mixed cortical cell cultures (mice)\                                                                                                                                                                                                                                             Exogenous 10 μg/ml                                 tPA attenuated zinc-induced neuronal death, independently of its proteolytic activity
                    Treatment: zinc (35 μmol/l)                                                                                                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                    

  [@B39]            *In vitro*: primary cultures of neurons (DIV 5--21) exposed to 1.4% isoflurane for 4 h\                                                                                                                                                                                                      Exogenous 0.03--3 μg/ml                            Isoflurane induced apoptosis at DIV 5 (but not DIV 14 or DIV 21) in cultured neurons tPA decreases isoflurane-induced cell death in primary cultures of neurons (DIV 5) Isoflurane-induced neurotoxicity in the developing rodent brain is mediated by reduced tPA synaptic release and enhanced proBDNF/p75NTR-mediated apoptosis
                    *In vivo*: 1.4% isoflurane (anesthetic mediated neurotoxicity in mice)                                                                                                                                                                                                                                                                          

                                                                                                                                                                                                                                                                                                                                                                    

  [@B27]            *In vitro*: cultures of hippocampal neurons (OGD conditions for 30 min (preconditioning) or not, followed 24 h later by incubation under OGD conditions for 55 min)                                                                                                                          Endogenous (tPA KO mice) and exogenous (0--1 μM)   Treatment after OGD (early preconditionning). Beneficial effect of tPA involving a LRP1 dependent signaling pathway and independent of its proteolytic activity.\
                                                                                                                                                                                                                                                                                                                                                                    Treatment 24 h after OGD (delayed preconditioning): beneficial effect of tPA via a NMDA-dependent signaling pathway (activation of pAkt), and activation of plasmin

                                                                                                                                                                                                                                                                                                                                                                    

  [@B123]           *In vitro:* cultures of cortical neurons (55 min OGD and then exposed 10 min later to a second episode of hypoxia (10 min OGD, post-conditioning))                                                                                                                                           Endogenous (transgenic mice T4)                    Decrease of the activation of mTor- HIFα, involving NMDAR

                                                                                                                                                                                                                                                                                                                                                                    

  [@B121]           *In vivo*: excitotoxin-induced neuronal death T4 mice and WT\                                                                                                                                                                                                                                T4 mice or IV 1 mg/Kg on WT mice                   tPA protected the brain from excitotoxin-induced cell death\
                    Intrastriatal injection of NMDA (50 mM)                                                                                                                                                                                                                                                                                                         Dose-dependent effect of tPA on NMDA-induced neuronal death -- 5 and 10 nM beneficial -- 100 at 500 nM deleterious

                                                                                                                                                                                                                                                                                                                                                                    \(1\) The neuroprotective effect of tPA was mediated by activation of synaptic GluN2A containing NMDAR via a plasminogen-independent mechanism\
                                                                                                                                                                                                                                                                                                                                                                    (2) ERK activation mediated the protective effect of tPA against excitotoxin-induced neuronal death

                    *In vitro:* cerebral cortical neurons (mice) NMDA induced neuronal death (50 M)                                                                                                                                                                                                              Exogenous 5--500 nM                                \(3\) tPA activated the ERK -CREB-Atf3 pathway\
                                                                                                                                                                                                                                                                                                                                                                    (4) Atf3-mediated the protective effect of tPA against excitotoxin-induced neuronal death

                                                                                                                                                                                                                                                                                                                                                                    

  [@B122]           *In vitro*: cultures of cortical neurons (OGD 55 min)                                                                                                                                                                                                                                        Endogenous (transgenic mice T4)                    Adaptation to metabolic stress -- AMPK activation involving NMDAR

                                                                                                                                                                                                                                                                                                                                                                    

  [@B41]            *Ex vivo*: cortical brain slices from postnatal P10 mice                                                                                                                                                                                                                                     Exogenous (20 μg/mL)                               tPA significantly reduced caspase-3 activity\
                                                                                                                                                                                                                                                                                                                                                                    In superficial layers (less mature), tPA alone inhibited apoptosis via EGFR

                                                                                                                                                                                                                                                                                                                                                                    

  **No effects**                                                                                                                                                                                                                                                                                                                                                    

  [@B114]           *In vitro:* spinal cords cultures of mice\                                                                                                                                                                                                                                                   Endogenous                                         tPA did not affect the vulnerability of cultured neurons to kainite
                    tPA --/-- and WT (DIV 10--12)\                                                                                                                                                                                                                                                                                                                  
                    Kainate-induced death of motoneurons (20 and 100 μM for 24 h)                                                                                                                                                                                                                                                                                   

                                                                                                                                                                                                                                                                                                                                                                    

  [@B113]           *In vivo:* primary cultures of rat cortical neurons\                                                                                                                                                                                                                                         Exogenous 10 μg/ml                                 tPA required plasminogen to inhibit Aβ toxicity and to block Aβ deposition\
                    Treatment: Aβ (16 or 25 μM) and plasminogen (30 nM)                                                                                                                                                                                                                                                                                             Degradation of Aβ fibrils is dependent on tPA and Plg proteolytic activity

                                                                                                                                                                                                                                                                                                                                                                    

  [@B30]            *In vitro:* cultured hippocampal neurons from rats (DIV 7--10)\                                                                                                                                                                                                                              Exogenous 1,000 IU                                 tPA resulted in a modest exaggeration of this injury
                    ± NMDA 10 μM                                                                                                                                                                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                                                                    

  [@B124]           *In vitro:* mixed cortical cell cultures (mice)\                                                                                                                                                                                                                                             Exogenous 10 μg/ml                                 Calcium-mediated neuronal death was not attenuated by tPA
                    Treatment: NMDA (30 μmol/l)                                                                                                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                    

  **Deleterious**                                                                                                                                                                                                                                                                                                                                                   

                                                                                                                                                                                                                                                                                                                                                                    

  [@B112]           *In vivo:* kainate induced neuronal death                                                                                                                                   Mouse tPA --/--                                                                                                  Endogenous                                         tPA is required to promote neuronal degeneration

                                                                                                                                                                                                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                                                                    

                                                                                                                                                                                                Mouse WT                                                                                                         120 μg tPA for 3 days (intra-parenchymal)          

                                                                                                                                                                                                                                                                                                                                                                    

  [@B116]           *In vitro:* PC12 cells and primary cultures of cortical neurons (rats; DIV 12--14)                                                                                                                                                                                                           Exogenous 50 μg/ml                                 tPA significantly increased hemoglobin-induced cell death

                                                                                                                                                                                                                                                                                                                                                                    

  [@B30]            *In vitro:* cultured hippocampal neurons on rats (DIV 7--10) ± plasminogen                                                                                                                                                                                                                   Exogenous 100 IU                                   Proteolytic action

                                                                                                                                                                                                                                                                                                                                                                    

  [@B80]            *In vitro*: mixed cortical cultures or near-pure neuronal cultures (mice)                                                                                                                                                                                                                    Exogenous 0.2--20 μg/ml                            tPA failed to modify the neurotoxicity induced by the exposure to a non-NMDA agonist (kainate)

                    Excitotoxicity: NMDA (10 or 12.5 μM) or 50 μM kainate\                                                                                                                                                                                                                                                                                          The catalytic activity of tPA enhanced neuronal death induced by exposure to NMDA\
                    Calcium imaging                                                                                                                                                                                                                                                                                                                                 tPA cleaves the GluN1 subunit of the NMDAR

                    *In vivo*: NMDA induced excitotoxic lesions (rats) (50 nmol)                                                                                                                                                                                                                                 Exogenous 3.0 μg (intra-parenchymal)               

                                                                                                                                                                                                                                                                                                                                                                    

  [@B33]            *In vitro:* cultured cortical neurons (mice)\                                                                                                                               Apoptosis: serum deprivation (DIV 7)Nifedipine (50 μM, DIV 14) Excitotoxicity (DIV 13--14)\                      Endogenous                                         TGF-α rescued neurons from NMDA-induced excitotoxicity in mixed cultures through inhibition of tPA activity, involving PAI-1 overexpression by an ERK-dependent pathway in astrocytes
                    Mixed cortical cultures of neurons and astrocytes (mice)                                                                                                                    12.5 μM of NMDA                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                    

  [@B59]            *In vivo*: kainate-induced excitotoxicity on tPA --/-- and WT mice (1.5 nmol of kainate)                                                                                                                                                                                                     Exogenous 1.85 μmol/L                              Infusion of tPA into tPA --/-- mice restored sensitivity to kainate-mediated neurotoxicity and activation of microglia

                    *In vivo*: NMDA-induced excitotoxicity in mice (50 mmol/L NMDA)                                                                                                                                                                                                                              Exogenous 46 μmol/L                                tPA increased the lesion volumes induced by NMDA injection into the striatum

                                                                                                                                                                                                                                                                                                                                                                    

  [@B60]            *In vitro:* pure cultures of mouse cortical neurons exposed to NMDA (12.5 μmol/L)                                                                                                                                                                                                            Exogenous 20 μg/ml                                 Proteolytic activity

                                                                                                                                                                                                                                                                                                                                                                    

  [@B62]            *In vitro*: primary neuronal cultures (mice; DIV 14)\                                                                                                                                                                                                                                        Exogenous 20 μg/ml                                 tPA potentiated apoptosis in mouse cortical neurons treated with *N*-methyl-[D]{.smallcaps}-aspartate (NMDA) by shifting the apoptotic pathway
                    NMDA treatment--induced apoptosis in neurons                                                                                                                                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                                                                    

  [@B6]             *In vivo:* striatal excitotoxic lesions (rats; NMDA 50 nmol)                                                                                                                                                                                                                                 Exogenous IV 1 mg/kg                               tPA potentiated excitotoxic lesions

                                                                                                                                                                                                                                                                                                                                                                    

  [@B54]            *In vivo*: excitotoxic lesions in mice induced by NMDA (10 nmol in striatum or 20 nmol in cortex)                                                                                                                                                                                            Endogenous                                         Overexpression of neuroserpin in the brain parenchyma might limit the deleterious effect of tPA on NMDAR-mediated neuronal death

                    *In vitro*: neuronal cortical cultures from mice                                                                                                                            Serum deprivation (DIV 7)                                                                                                                                           

                    Treatment: neuroserpin (0.5--1 μM)                                                                                                                                          Excitotoxic paradigms (DIV 13--14) NMDA (12.5 μmol/l)\                                                                                                              
                                                                                                                                                                                                AMPA (10 μmol/l)\                                                                                                                                                   
                                                                                                                                                                                                Calcium videomicroscopy                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                    

  [@B75]            *In vitro*: mouse neuroblastoma N2a cells; primary cultures of hippocampal neurons tPA --/-- or WT (mouse)                                                                                                                                                                                   Exogenous 20 μg/ml                                 tPA induced Erk1/2 activation in neurons (independently of plasmin), tau phosphorylation and promoted A-beta mediated apoptosis\
                                                                                                                                                                                                                                                                                                                                                                    tPA treatments induced GSK3 activation, tau hyperphosphorylation, microtubule destabilization and apoptosis in hippocampal neurons

                                                                                                                                                                                                                                                                                                                                                                    

  [@B7]             *In vivo* studies: Excitotoxic lesions in mice performed by injection of NMDA (10 nmol) into the striatum\                                                                                                                                                                                   Exogenous\                                         Immunization against the NTD of the GluN1 subunit of NMDAR prevented the neurotoxic effect of endogenous and exogenous tPA
                    *In vivo* studies: permanent MCAO in mice                                                                                                                                                                                                                                                    1 mg/kg                                            

                                                                                                                                                                                                                                                                                                                                                                    

  [@B63]            *In vivo:* striatal excitotoxic lesions (rats; 50 nmol)                                                                                                                                                                                                                                      Exogenous IV 1 mg/kg                               tPA increased lesion volumes induced by NMDA (+40%)

                                                                                                                                                                                                                                                                                                                                                                    

  [@B64]            *In vitro:* pure neuronal cultures (mice)                                                                                                                                   Excitotoxicity (NMDA 10 μmol/L)\                                                                                 Exogenous 0.3 μmol/L                               Interaction of tPA with GluN1 led to a subsequent potentiation of NMDA-induced calcium influx and neurotoxicity
                                                                                                                                                                                                Calcium videomicroscopy (NMDA 12.5--100 μmol/L)                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                    

  [@B118]           *In vitro*: hippocampal slices from P12 rats (OGD 30 min)\                                                                                                                                                                                                                                   Exogenous 0.9 μg/ml                                Addition of tPA after OGD enhanced neuronal death in CA1 and XG-102 administration reduced neuronal death, alone or in the presence of tPA
                    Treatment: c-Jun N-terminal kinase inhibitor (XG-102; 12 nM 6 h after OGD)                                                                                                                                                                                                                                                                      

                                                                                                                                                                                                                                                                                                                                                                    

  [@B106]           *In vitro:* cultured dopaminergic neuroblasts (rat; N27 line)\                                                                                                                                                                                                                               Exogenous 10--20 μg/ml                             tPA induced N27 neuroblast cell death. Aprotinin and other protease inhibitors led to an inhibition of tPA-mediated neurotoxicity\
                    Treatments: aprotinine (200 KIU/ml), 𝜀-aminocaproic acid (2 mM), EGRck (Glu--Gly--Arg--CH2Cl, 100 mg/ml), FPRck (Phe--Pro--Arg--CH2Cl, 100 mg/ml), bivalirudin (20 mg/ml)                                                                                                                                                                       Aprotinin, FPRck, and EGRck directly antagonized the proteolytic activity of tPA, whereas 𝜀-aminocaproic acid inhibited the binding of tPA to lysine residues on the cell surface

                                                                                                                                                                                                                                                                                                                                                                    

  [@B5]             *In vitro* study: cortical and hippocampal neurons from mice (DIV 7 or DIV 12--14). Excitotoxic neuronal death (NMDA 50 μM)                                                                                                                                                                  Exogenous 20 μg/ml                                 Catalytic tPA promoted NMDAR-induced Erk(1/2) MAPK activation\
                                                                                                                                                                                                                                                                                                                                                                    tPA failed to potentiate excitotoxicity of hippocampal neurons lacking GluN2D\
                                                                                                                                                                                                                                                                                                                                                                    tPA exacerbated neurotoxicity through GluN2D-containing NMDAR via Erk 1/2

                    *In vivo*: excitotoxic lesions. Male Swiss mice Hippocampal or cortical bilateral injections of NMDA                                                                                                                                                                                         Exogenous IV 10 mg/kg                              

                                                                                                                                                                                                                                                                                                                                                                    

  [@B35]            *In vitro:* mouse cortical neurons (DIV14)\                                                                                                                                                                                                                                                  Exogenous 20 μg/ml                                 The anticoagulant factor protein S (PS) protects mouse cortical neurons from tPA/NMDA induced injury. PS blocks the extrinsic apoptotic cascade
                    Neuronal apoptosis model                                                                                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                    

  [@B46]            *In vitro*: cortical and hippocampal neurons (mice; DIV 12--13)\                                                                                                                                                                                                                             Exogenous 20 μg/mL                                 tPA increased NMDA-mediated neurotoxicity in cortical neuronal cultures but not in hippocampal neuronal cultures\
                    Excitotoxic neuronal death: NMDA (10 μM)\                                                                                                                                                                                                                                                                                                       UBP145 had no effect on NMDA-mediated neurotoxicity in hippocampal neurons but prevented tPA-induced potentiation of NMDA-mediated neurotoxicity in cortical neurons
                    Treatment: UBP145 (0.2 μM)                                                                                                                                                                                                                                                                                                                      

                    *In vivo:* cortical excitotoxic lesions NMDA (mice; 2.5 nmol)\                                                                                                                                                                                                                               Exogenous IV 10 mg/kg                              Inhibition of GluN2D-containing NMDAR with UBP145 can fully prevent the pro-excitotoxic effect of intravenously administered tPA
                    Treatment: UBP145 (0.05 nmol)                                                                                                                                                                                                                                                                                                                   

                                                                                                                                                                                                                                                                                                                                                                    

  [@B98]            *In vitro:* primary mixed cortical cell cultures from rats (OGD 150 min)                                                                                                                                                                                                                     Exogenous 5 mg/mL                                  Treatment with tPA after OGD increased LDH release, active MMP-9, MCP-1, and MIP-2\
                                                                                                                                                                                                                                                                                                                                                                    Treatment with neuroserpin after OGD decreased LDH release and active MMP-9

                                                                                                                                                                                                                                                                                                                                                                    

  [@B100]           *In vitro:* primary cultures of cortical neurons (mice; DIV 10) Excitotoxicity induced by 10 μM NMDA\                                                                                                                                                                                        Exogenous 0.3 μM                                   HMGB-1 reversed the pro-neurotoxic effect of tPA\
                    Treatment: HMGB-1 0.3 μM                                                                                                                                                                                                                                                                                                                        HMGB-1 prevented tPA from potentiating NMDA-evoked\
                                                                                                                                                                                                                                                                                                                                                                    Ca^2+^ influx

                                                                                                                                                                                                                                                                                                                                                                    

  [@B66]            *In vitro:* cultures of cortical neurons (rats; OGD/R)\                                                                                                                                                                                                                                      Endogenous                                         Neuroserpin protected neurons against OGD/R. mainly by inhibiting tPA-mediated acute neuronal excitotoxicity
                    Treatment: neuroserpin                                                                                                                                                                                                                                                                                                                          

                                                                                                                                                                                                                                                                                                                                                                    

  [@B76]            *In vitro:* cortical cultures of neurons from mice (DIV 12--13)\                                                                                                            Excitotoxicity NMDA (10 μmol/L)\                                                                                 Exogenous 0.3 μmol/L                               Memantine prevented the potentiation of excitotoxic neuronal death induced by rtPA\
                    Treatment: memantine (1--10 μmol/L)                                                                                                                                         OGD (30 min)\                                                                                                                                                       Memantine prevented rtPA-exacerbated calcium influx through activated NMDAR
                                                                                                                                                                                                Calcium videomicroscopy NMDA (50 μmol/L)                                                                                                                            

                    *In vitro:* cultures of cortical neurons from mice (DIV 15--16)\                                                                                                                                                                                                                             Exogenous 0.3 μM                                   In contrast to WT tPA, tPA mutants including deletion of the kringle 2 domain and point mutation of the LBS-containing kringle 2 domain did not promote NMDAR-mediated neurotoxicity
                    Excitotoxic neuronal death: NMDA 50 μM                                                                                                                                                                                                                                                                                                          

                                                                                                                                                                                                                                                                                                                                                                    

  [@B86]            *In vitro*                                                                                                                                                                  Excitotoxicity induced by exposure of cortical neurons to NMDA (mice; 50 μM) at DIV 14                           Exogenous 0.3 μM                                   sc-tPA promoted NMDAR-mediated neurotoxicity through its proteolytic activity, tc-tPA did not sc-tPA promoted both NMDA-induced calcium influx and Erk (½) activation, tc-tPA did not

                                                                                                                                                                                                NMDA-induced calcium influx recorded from cultured cortical neurons (mice; DIV 12--14) exposed to NMDA (50 μM)                                                      

                    *In vivo*                                                                                                                                                                   NMDA-induced excitotoxic brain lesions (NMDA 10 mM)                                                              Exogenous 45 μM                                    

                                                                                                                                                                                                                                                                                                                                                                    

  [@B41]            *Ex vivo:* cortical brain slices from postnatal P10 mice                                                                                                                                                                                                                                     Exogenous 20 μg/mL                                 In deeper layers (more mature), tPA was associated with glutamate-promoted neuronal necrosis

                                                                                                                                                                                                                                                                                                                                                                    

  [@B82]            *In vivo:* excitotoxic insult by intra-cortical injection of Ibotenate in rats PAI-1 or tPA --/-- or WT\                                                                                                                                                                                     Endogenous or exogenous 20 μg/ml                   Neonatal brain lesions
                    *Ex vivo*: brain sections                                                                                                                                                                                                                                                                                                                       
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Are Target Receptors the Explanations?
--------------------------------------

In the brain parenchyma, pro-survival and pro-neurotoxic effects of tPA have been shown to involve key receptors/pathways, including NMDAR ([@B80]), LRP-mediated PSD95 activation ([@B72]), annexin-II ([@B103]), and EGF receptor ([@B61]; [@B56]). Focusing on NMDARs, the fact that tPA induces toxic or protective effects could also depend on the different subtypes of GluN subunits involved, and/or their location (synaptic versus extrasynaptic; [@B85]). For instance, based on the current literature, it could be postulated that exogenous tPA could promote neurotoxicity on cortical neurons by activating extrasynaptic GluN2D-containing NMDARs ([@B5]; [@B46]; [@B76]), but could lead to a neuroprotective effect by activating synaptic GluN2A-containing NMDARs ([@B121]; **Figure [3B](#F3){ref-type="fig"}**). Several studies also propose that the neuroprotective activity of tPA, even in a paradigm involving NMDARs, is NMDAR-independent ([@B24]), independent of its proteolytic activity ([@B61]). In a model of apoptosis induced by serum deprivation ([@B61]) or when subjected to OGD, the neuroprotective effect of tPA is mediated by an activation of either EGFR ([@B24]; [@B10]; [@B56]) or annexin II ([@B55]). Whether LRP is also involved is still under debate, again dependent on the paradigm used ([@B72]). Up to now, it is not clear how these different receptors contribute to the differential effects of tPA in neuronal survival. Additional studies are needed including investigations about possible crosstalks between these different receptors.

Are Protocols of Neuronal Injury the Explanation?
-------------------------------------------------

Type plasminogen activator-dependent over-activation of NMDARs has been proposed as a mechanism that could mediate both neuroprotective ([@B122]) and neurotoxic ([@B5]) effects of tPA (**Figure [3B](#F3){ref-type="fig"}**). This discrepancy may be explained by the use of different models to induce neuronal death, either pure NMDAR-mediated excitotoxicity ([@B5]) or oxygen glucose deprivation (OGD; [@B122]). Whether OGD induces excitotoxicity and/or apoptosis is not well documented and might depend on the severity/duration of the stress. Pathways such as autophagy or endoplasmic reticulum stress may also occur ([@B3]; [@B102]). Another explanation could be the use of differential strategies to block tPA-induced potentiation of NMDAR signaling, MK-801 as a broad irreversible antagonist of NMDARs on one hand ([@B108]) and an antibody previously characterized to specifically prevent the tPA-dependent potentiation of NMDARs signaling without affecting their basal activity ([@B7]; [@B68]) on the other hand. It is interesting to note that either over-activation and blockage of NMDARs are neurotoxic, the first one leading to excitotoxic neuronal death ([@B80]), the second one inducing apoptosis ([@B73]; [@B41]).

Is Neuronal Maturity an Explanation?
------------------------------------

To discuss the differential impact of tPA on neuronal survival, how neurons are mature is also an important issue including whether experiments were performed *in vitro* (neuronal cultures performed from E16 embryo and maintained different times *in vitro*, 5--14 days ([@B14]; [@B101]), *ex vivo* (hippocampal slices harvested at P3 and maintained different times *in vitro*; [@B56]) or *in vivo* (young versus aged animals; [@B99]). For example, it was well-demonstrated that mouse primary cultures of cortical neurons become sensitive to NMDA-induced neuronal death only after 10 days *in vitro*, an effect potentiated by exogenous tPA ([@B53]). At early times (days *in vitro*), they require trophic factors contained in the culture media (serum) to survive ([@B42]; [@B108]). When removed, serum deprivation led to neuronal apoptosis with a protective effect of exogenous tPA ([@B61]). Type of neurons may also be critical, with neurotoxic effects of tPA mainly described in cortical neurons ([@B80]) or Purkinje neurons ([@B23]; [@B58]; **Figures [3B,C](#F3){ref-type="fig"}**). The protective effect of tPA was described on hippocampal neurons ([@B30]; [@B27]; [@B56]; **Figure [3A](#F3){ref-type="fig"}**) and on cortical neurons ([@B61]; [@B121]; **Figure [3B](#F3){ref-type="fig"}**).

Does the Origin of tPA (Endogenous vs. Exogenous) make the Difference?
----------------------------------------------------------------------

Another important point of discussion is to know whether exogenous and endogenous tPA have differential effects on neuronal survival. The most recent literature in this field demonstrates that endogenous tPA displays neuroprotective activities ([@B121]; [@B56]) and exogenous tPA is neurotoxic ([@B86]). Nevertheless, using tPA deficient mice, exogenous tPA may also protect hippocampal neurons subjected to OGD ([@B56]). These data suggest that tPA (exogenous or endogenous) may have either pro-neurotoxic or pro-survival effects depending of the type of stress paradigms used and/or the type of neurons. Thus, whether experiments are performed on wild type neurons, tPA deficient neurons, tPA over-expressing neurons, *in vitro* and *in vivo*, is important to understand the impacts of tPA on neuronal survival ([@B112]; [@B117]; [@B80]; [@B61]; [@B27]; [@B121]).

What about the Level of tPA?
============================

Some authors suggest that low levels of tPA are neuroprotective ([@B121]), either exogenous ([@B5]) or produced by stressed cells ([@B56]). In contrast, high levels of tPA (mainly exogenous) are neurotoxic ([@B80]; [@B86]).

Finally, Why not the Form of tPA?
---------------------------------

There is so far only one study which discriminated tPA isoforms in the context of neuronal survival, with a clear evidence that sc-tPA is the only one capable to activate NMDAR and to promote excitotoxicity (in mouse cortical neurons subjected to NMDA exposure) both *in vitro* and *in vivo* ([@B86]; [@B10]). It is thus interesting to note, that complexes formed between sc-tPA and neuroserpin (NSP) were reported more stable than those formed between tc-tPA and NSP, with no differences when complexes are formed with PAI-1 ([@B4]). Whether conversion of sc-tPA into tc-tPA (by plasmin like activity) may influence the functions of tPA on neuronal survival, especially in the context of brain injuries, need to be investigated.

Conclusion
==========

Depending on the study, endogenous tPA was reported as deleterious or beneficial for neurons. Although it is difficult to reconcile these findings, some propose that tPA is neuroprotective at low levels, but neurotoxic at higher levels. Assays of extracellular levels of tPA under specific conditions should be provided to support this hypothesis. Undoubtedly, the target involved is also a key trigger in the effect of tPA. In general, the pro-survival effects of tPA are independent on its proteolytic activity involving, interconnected or independently, EGF receptors, annexin II, PI-3 kinase-, AMPK-, mTor-HIF-1alpha-dependent signaling pathways. In the adult, the neurotoxic effects of tPA seem to be dependent on its proteolytic activity, targeting either plasminogen, NMDARs, components of the extracellular matrix, inflammatory mediators, and/or other proteases. However, indirect neurotoxicity might also occur via a non-proteolytic activation of microglia ([@B103]). For now, there is no clear clinical data to determine, in human, whether tPA is neurotrophic or neurotoxic and in what conditions. Additional studies are needed to understand further the possible differential functions of tPA on neuronal survival. To address this question, we should consider the different isoforms of tPA (type I sc-tPA, type I tc-tPA, type II sc-tPA, and type II tc-tPA), the possibility that tPA may activate its substrates and/or receptors with differential affinities and that these substrates and/or receptors could be differentially expressed in cortical versus hippocampal neurons depending on their maturity.
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